Boston Scientific was the worst performer in the S&P 500 Wednesday after the medical-device maker beat earnings expectations but offered a disappointing outlook for the current quarter.

As the 2026 Winter Olympics get underway in Italy this week, Eli Lilly—a partner of both Team USA and the Milan Cortina Games as a whole—is rolling out a new corporate campaign inspired by the event.

As requested by the General Assembly, the United Nations Secretary-General has launched an open call for candidates to serve on the Independent International Scientific Panel on Artificial ...

Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance that slightly fell short of elevated investor expectations. This response was ...

Boston Scientific’s share price — which medical device competitors have long envied — sputtered Feb. 4 after the company reported softer sales than expected in its blockbuster division treating heart ...

Feb 4 (Reuters) - Boston Scientific (BSX.N), opens new tab on Wednesday reported lower-than-expected quarterly sales in its key electrophysiology division, dragging the medical device maker's shares ...

Boston Scientific (BSX) lost ~9% in the premarket on Wednesday after the MedTech giant indicated an underwhelming outlook for 2026 with its Q4 2025 results, which, however, beat Street forecasts ...

Elon Musk’s SpaceX has filed plans with U.S. regulators to launch up to one million satellites into low-Earth orbit. Together, these satellites will act as an orbital data center to power artificial ...

The latest death data for the U.S. are in, and they paint an optimistic picture: The average American born in 2024 is now expected to live to age 79. That life expectancy is more than a half-year ...